N Almuhanna, R Alhamazani, S Alkhezzi, MT Alfataih… - JAAD Case Reports, 2023 - Elsevier
Discussion Due to its rarity and lack of Food and Drug Administration approved treatment,
LABD in children is difficult to treat. Systemic dapsone is the most common first-line …